The company's decision to amend the certificates of designation aims to adjust the terms of the preferred stock without altering the current number of shares. DarioHealth, a Delaware-incorporated company with a market capitalization of approximately $29 million, specializes in surgical and medical instruments and apparatus. It operates under the name 08 Industrial Applications and Services and is headquartered in New York, NY. Despite challenging market conditions, the company has achieved notable revenue growth of 47% in the last twelve months. Get deeper insights into DarioHealth's financial health and growth prospects with InvestingPro 's comprehensive research report, part of its coverage of over 1,400 US stocks. The full text of the amended certificates can be found in the exhibits attached to the Form 8-K filed with the SEC. This report is based on a press release statement from DarioHealth Corp.